Use of gene expression and alternative splicing signatures to discriminate breast cancer stem cells from fibroblasts.
David T. Weaver
Consultant or Advisory Role - Verastem
Irina M Shapiro
Stock Ownership - Verastem
Alan G Derr
Consultant or Advisory Role - Verastem
Daniel Paterson
Consultant or Advisory Role - Verastem
Jonathan A Pachter
Stock Ownership - Verastem